» Articles » PMID: 20034678

Expression of Toll-like Receptor 2 in Duodenal Biopsies from Dogs with Inflammatory Bowel Disease is Associated with Severity of Disease

Overview
Date 2009 Dec 26
PMID 20034678
Citations 23
Authors
Affiliations
Soon will be listed here.
Abstract

There is growing evidence that aberrant innate immune responses towards the bacterial flora of the gut play a role in the pathogenesis of canine inflammatory bowel disease (IBD). Toll-like receptors (TLR) play an important role as primary sensors of invading pathogens and have gained significant attention in human IBD as differential expression and polymorphisms of certain TLR have been shown to occur in ulcerative colitis (UC) and Crohn's disease (CD). The aim of the current study was to evaluate the expression of two TLR important for recognition of commensals in the gut. TLR2 and TLR4 mRNA expression in duodenal biopsies from dogs with IBD was measured and correlated with clinical and histological disease severity. Endoscopic duodenal biopsies from 20 clinical cases and 7 healthy control dogs were used to extract mRNA. TLR2 and TLR4 mRNA expression was assessed using quantitative real-time PCR. TLR2 mRNA expression was significantly increased in the IBD dogs compared to controls, whereas TLR4 mRNA expression was similar in IBD and control cases. In addition, TLR2 mRNA expression was mildly correlated with clinical severity of disease, however, there was no correlation between TLR2 expression and histological severity of disease.

Citing Articles

Sulfate-Reducing Bacteria Induce Pro-Inflammatory TNF-α and iNOS via PI3K/Akt Pathway in a TLR 2-Dependent Manner.

Singh S, Braun C, Carroll-Portillo A, Coffman C, Lin H Microorganisms. 2024; 12(9).

PMID: 39338507 PMC: 11434237. DOI: 10.3390/microorganisms12091833.


Effects of NBF 2 DSM 32264 Consumption on the Body Weight, Body Condition Score, Fecal Parameters, and Intestinal Microbiota of Healthy Persian Cats.

Bela B, Di Simone D, Pignataro G, Fusaro I, Gramenzi A Vet Sci. 2024; 11(2).

PMID: 38393079 PMC: 10893002. DOI: 10.3390/vetsci11020061.


Canine chronic enteropathy-Current state-of-the-art and emerging concepts.

Jergens A, Heilmann R Front Vet Sci. 2022; 9:923013.

PMID: 36213409 PMC: 9534534. DOI: 10.3389/fvets.2022.923013.


Elucidating the Role of Innate and Adaptive Immune Responses in the Pathogenesis of Canine Chronic Inflammatory Enteropathy-A Search for Potential Biomarkers.

Siel D, Beltran C, Martinez E, Pino M, Vargas N, Salinas A Animals (Basel). 2022; 12(13).

PMID: 35804545 PMC: 9264988. DOI: 10.3390/ani12131645.


Nonpharmacological Treatment Strategies for the Management of Canine Chronic Inflammatory Enteropathy-A Narrative Review.

Isidori M, Corbee R, Trabalza-Marinucci M Vet Sci. 2022; 9(2).

PMID: 35202290 PMC: 8878421. DOI: 10.3390/vetsci9020037.